35Indexed trials
mesh condition
Central Nervous System Diseases
Intelligence
Central Nervous System Diseases intelligence: 35 indexed trials, 11 recruiting studies, 31 sponsors across 36 countries.
11Recruiting
31Sponsors
36Countries
Leading sponsors
Novartis40 recruiting
Tammie L. S. Benzinger, MD, PhD21 recruiting
Beijing Friendship Hospital10 recruiting
Comenius University11 recruiting
Connecta Therapeutics, S.L.11 recruiting
Danilo Toni10 recruiting
Eisai Co., Ltd.10 recruiting
Danish Research Centre for Magnetic Resonance11 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Grethe Andersen10 recruiting
Children's Hospital Medical Center, Cincinnati10 recruiting
Geographic activity
United States16trials
France7trials
Canada6trials
Spain6trials
United Kingdom6trials
Sweden4trials
China3trials
Poland3trials
Italy3trials
Lithuania2trials
Finland2trials
Bulgaria2trials
Leading interventions
CAD1063trials
F 18 T8072trials
E20202trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
ACI-24.060 at Dose C in Study Part 1a1trials
Active patterned repetitive transcranial magnetic stimulation (prTMS)1trials
BGG4921trials
BPN147701trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
ACI-24.060 at Dose B in Study Part 21trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.